Mizuta, H., Furugaki, K., Shu, S., Kawasaki, N., Yoshiura, S., Yamashita-Kashima, Y. (2025). Mosunetuzumab and lenalidomide combination therapy augments CD8+ T cells with enhanced T cell-dependent cytotoxicity against follicular lymphoma cells. Blood. https://doi.org/10.1182/blood-2025-1806